Literature DB >> 32246831

Human airway epithelial cells express a functional IL-5 receptor.

Karina T Barretto1, Rebecca A Brockman-Schneider1, Ine Kuipers1, Sarmila Basnet1, Yury A Bochkov1, Matthew C Altman2,3, Nizar N Jarjour4, James E Gern1, Stephane Esnault4.   

Abstract

Entities:  

Keywords:  IL-5 receptor; RNA-sequencing; airway epithelial cells; gene expression; intracellular signaling

Mesh：

Substances：

Year:  2020        PMID： 32246831      PMCID： PMC7387204          DOI： 10.1111/all.14297

Source DB:  PubMed          Journal:  Allergy        ISSN： 0105-4538            Impact factor:   13.146


× No keyword cloud information.
  9 in total

1.  Cadherin-related family member 3, a childhood asthma susceptibility gene product, mediates rhinovirus C binding and replication.

Authors:  Yury A Bochkov; Kelly Watters; Shamaila Ashraf; Theodor F Griggs; Mark K Devries; Daniel J Jackson; Ann C Palmenberg; James E Gern
Journal:  Proc Natl Acad Sci U S A       Date:  2015-04-06       Impact factor: 11.205

2.  Transduction of a dominant-negative H-Ras into human eosinophils attenuates extracellular signal-regulated kinase activation and interleukin-5-mediated cell viability.

Authors:  D J Hall; J Cui; M E Bates; B A Stout; L Koenderman; P J Coffer; P J Bertics
Journal:  Blood       Date:  2001-10-01       Impact factor: 22.113

Review 3.  Essential Mechanisms of Differential Activation of Eosinophils by IL-3 Compared to GM-CSF and IL-5.

Authors:  Stephane Esnault; Elizabeth A Kelly
Journal:  Crit Rev Immunol       Date:  2016       Impact factor: 2.214

4.  Chemoattractant-induced signaling via the Ras-ERK and PI3K-Akt networks, along with leukotriene C4 release, is dependent on the tyrosine kinase Lyn in IL-5- and IL-3-primed human blood eosinophils.

Authors:  Yiming Zhu; Paul J Bertics
Journal:  J Immunol       Date:  2010-11-24       Impact factor: 5.422

Review 5.  Anti-IL-5 treatments in patients with severe asthma by blood eosinophil thresholds: Indirect treatment comparison.

Authors:  William Busse; Geoffrey Chupp; Hiroyuki Nagase; Frank C Albers; Scott Doyle; Qin Shen; Daniel J Bratton; Necdet B Gunsoy
Journal:  J Allergy Clin Immunol       Date:  2018-09-08       Impact factor: 10.793

6.  Eosinophilic inflammation is associated with elevation of interleukin-5 in the airways of patients with spontaneous symptomatic asthma.

Authors:  S Sur; G J Gleich; M C Swanson; K R Bartemes; D H Broide
Journal:  J Allergy Clin Immunol       Date:  1995-11       Impact factor: 10.793

Review 7.  Interleukin-5 and IL-5 receptor in health and diseases.

Authors:  Kiyoshi Takatsu
Journal:  Proc Jpn Acad Ser B Phys Biol Sci       Date:  2011       Impact factor: 3.493

Review 8.  Phenotypic and genetic aspects of epithelial barrier function in asthmatic patients.

Authors:  Matthew Loxham; Donna E Davies
Journal:  J Allergy Clin Immunol       Date:  2017-06       Impact factor: 10.793

Review 9.  The Biology of Eosinophils and Their Role in Asthma.

Authors:  Claire N McBrien; Andrew Menzies-Gow
Journal:  Front Med (Lausanne)       Date:  2017-06-30
  9 in total
  5 in total

Review 1.  Rethinking neutrophils and eosinophils in chronic rhinosinusitis.

Authors:  Tim Delemarre; Bruce S Bochner; Hans-Uwe Simon; Claus Bachert
Journal:  J Allergy Clin Immunol       Date:  2021-04-21       Impact factor: 14.290

2.  Single-Cell and Population Transcriptomics Reveal Pan-epithelial Remodeling in Type 2-High Asthma.

Authors:  Nathan D Jackson; Jamie L Everman; Maurizio Chioccioli; Luigi Feriani; Katherine C Goldfarbmuren; Satria P Sajuthi; Cydney L Rios; Roger Powell; Michael Armstrong; Joe Gomez; Cole Michel; Celeste Eng; Sam S Oh; Jose Rodriguez-Santana; Pietro Cicuta; Nichole Reisdorph; Esteban G Burchard; Max A Seibold
Journal:  Cell Rep       Date:  2020-07-07       Impact factor: 9.423

Review 3.  Biological Therapy of Severe Asthma and Nasal Polyps.

Authors:  Agamemnon Bakakos; Florence Schleich; Petros Bakakos
Journal:  J Pers Med       Date:  2022-06-16

4.  Increased IL-6 and Potential IL-6 trans-signalling in the airways after an allergen challenge.

Authors:  Stephane Esnault; Mehdi Khosravi; Elizabeth A Kelly; Lin Ying Liu; Yury A Bochkov; Matthew C Tattersall; Nizar N Jarjour
Journal:  Clin Exp Allergy       Date:  2021-02-02       Impact factor: 5.018

5.  Mepolizumab targets multiple immune cells in aspirin-exacerbated respiratory disease.

Authors:  Kathleen M Buchheit; Erin Lewis; Deborah Gakpo; Jonathan Hacker; Aaqib Sohail; Faith Taliaferro; Evans Berreondo Giron; Chelsea Asare; Marko Vukovic; Jillian C Bensko; Daniel F Dwyer; Alex K Shalek; Jose Ordovas-Montanes; Tanya M Laidlaw
Journal:  J Allergy Clin Immunol       Date:  2021-06-16       Impact factor: 14.290
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.